Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jing Hughes

Immunomodulatory Activity of Humanized Anti–IL-7r Monoclonal Antibody RN168 in Subjects With Type 1 Diabetes

JCI insight

Medicine

2019

English

Studying the Effects of Glucagon-Modulators on the Activity of Second Messengers in Subcellular Compartments of Pancreatic Islet Cells

Biophysical Journal

Biophysics

2017

English

Related publications

Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40

Cancer Research

Oncology

2005

English

Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes

PLoS ONE

Multidisciplinary

2013

English

Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-Α, in Adults With Type 1 Diabetes

AAPS Journal

Pharmaceutical Science

2020

English

Anti-Antibody Activity of a Monoclonal Macroglobulin

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

1971

English

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Safety Profile and Clinical Activity of Multiple Subcutaneous Doses of MEDI-528, a Humanized Anti-Interleukin-9 Monoclonal Antibody, in Two Randomized Phase 2a Studies in Subjects With Asthma

BMC Pulmonary Medicine

Pulmonary

Respiratory Medicine

2011

English

Anti-Il-7 Receptor Α Monoclonal Antibody (GSK2618960) in Healthy Subjects - A Randomised, Double-Blind Placebo-Controlled Study

British Journal of Clinical Pharmacology

Pharmacology

2018

English

Pharmacokinetics of Tildrakizumab (MK-3222), an Anti-Il-23 Monoclonal Antibody, Following Intravenous or Subcutaneous Administration in Healthy Subjects

Basic and Clinical Pharmacology and Toxicology

English

Matrix Metalloproteinases in Subjects With Type 1 Diabetes

BMC Clinical Pathology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jing Hughes

Immunomodulatory Activity of Humanized Anti–IL-7r Monoclonal Antibody RN168 in Subjects With Type 1 Diabetes

Studying the Effects of Glucagon-Modulators on the Activity of Second Messengers in Subcellular Compartments of Pancreatic Islet Cells

Related publications

Preclinical Antilymphoma Activity of a Humanized Anti-Cd40 Monoclonal Antibody, SGN-40

Inhibition of Increased Circulating TFH Cell by Anti-Cd20 Monoclonal Antibody in Patients With Type 1 Diabetes

Model-Based Characterization of the Pharmacokinetics, Target Engagement Biomarkers, and Immunomodulatory Activity of PF-06342674, a Humanized mAb Against IL-7 Receptor-Α, in Adults With Type 1 Diabetes

Anti-Antibody Activity of a Monoclonal Macroglobulin

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Safety Profile and Clinical Activity of Multiple Subcutaneous Doses of MEDI-528, a Humanized Anti-Interleukin-9 Monoclonal Antibody, in Two Randomized Phase 2a Studies in Subjects With Asthma

Anti-Il-7 Receptor Α Monoclonal Antibody (GSK2618960) in Healthy Subjects - A Randomised, Double-Blind Placebo-Controlled Study

Pharmacokinetics of Tildrakizumab (MK-3222), an Anti-Il-23 Monoclonal Antibody, Following Intravenous or Subcutaneous Administration in Healthy Subjects

Matrix Metalloproteinases in Subjects With Type 1 Diabetes